OClawVPS.com
Teva Pharmaceuticals
Edit

Teva Pharmaceuticals

http://www.tevapharm.com/
Last activity: 24.03.2026
Active
Categories: ContentCorporateHealthTechInformationMedTechPageProductSocialSpecialtyWebsite
This Facebook page will be used for sharing company news and information about Teva Pharmaceuticals globally, managed by the Corporate Communications team on Teva’s behalf.
This Facebook page is primarily for discussing news, events, featured business activities as well as topics related to health and wellness. We are excited to interact with you on our social channels, and look forward to fruitful and engaging dialogue.
This is not a forum to discuss treatments or conditions, or as a venue for reporting adverse events or side effects. If you have a specific question about our products or services, please visit the Contact Us section of our corporate website: https://www.tevapharm.com/contact-us/

If you are reporting an adverse event or side effect relating to one of our products, please contact Safety.AE@teva.co.il or submit your information through the Contact Us section of our corporate website at https://www.tevapharm.com/contact-us/.

If you are having a life-threatening emergency, please contact your physician or seek local emergency assistance.

We welcome your interactions, and we’ll try to reply to questions in a timely manner. Due to the limitations of these social channels and the regulated nature of the pharmaceutical industry, our replies may be brief. When possible, we will try to direct you to additional relevant information or support.

Teva’s corporate social accounts will be regularly monitored and updated during business hours, Monday to Friday. Comments or questions posted outside of this time will be responded to as soon as possible during business hours. Social channels may occasionally be unavailable and we accept no responsibility for lack of service due to the channel platform’s downtime.

When interacting with Teva on social channels, we encourage you to be respectful and polite; and to avoid sharing fraudulent, personally identifying, or confidential content. We will not respond to foul language; disparaging, defamatory, or inflammatory comments; or topics unrelated to Teva, and we reserve the right to delete inappropriate comments from our page as necessary.

Disclaimers:
We cannot share specific information about our products; for product-related information, please visit the relevant country or product website or submit your question through our website: https://www.tevapharm.com/contact-us/

We cannot comment on or respond to issues related to legal and financial matters, regulatory issues, or proprietary information on social channels.

Our social accounts may provide links to independent third-party sites in posts and tweets. Teva has no way of controlling the content of the content of third-party sites, nor does Teva endorse, or is Teva responsible for, the content on third-party sites.
Teva does not endorse, and is not responsible for, the content of any social accounts that the Teva social accounts follow.
Likes
44.82K
Followers
807.22K
Website visits
125.1K /mo.
Mentions
155
Location: Israel, Tel Aviv District, Tel Aviv-Yafo
Employees: 10001+
Founded date: 1901

Investors 1

DateNameWebsite
-Thomas H. ...thl.com

Mentions in press and media 155

DateTitleDescription
24.03.2026Fosun Pharma Announces 2025 Annual ResultsInnovation and Globalization Propel Fosun Pharma's High-Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock code: 600196.SH; 02196.HK), an innovation-driven global pharmace...
05.03.2026Defense giant Elbit becomes Israel’s most valuable company, after 45% surge this yearDefense giant Elbit Systems becomes the largest Israeli firm by market value listed on the Tel Aviv Stock Exchange after surpassing Teva Pharmaceuticals Industries and the country’s biggest lenders, Bank Hapoalim and Bank Leumi. Elbit share...
09.02.2026Indiana reaches $6.25M settlement with pharmaceutical companies over EpiPen pricesPlease subscribe to IBJ to decode this article. iiw oofnectst ncoiapcpw> lillau ser=ctitaeae"s/a-l"tan ahnudcltil igneircnmpnfpes.nisd pEtu nitr ann= apoteletwon-vaeia rroyrGeokhsp"et-snjad aacgir aertowuVist/cuas,"t ...
12.09.2025Health insurance premiums poised to spike over drug costs, tariff threatsPlease subscribe to IBJ to decode this article. enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t...
29.08.2025Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US CourtSeminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court Fri, Aug 29, 2025 13:30 CET Report this content Uppsala, Sweden – August 29, 2025 – Orexo (publ.), (STO:ORX) (OTCQX:ORXOY) in collaboration with its advisory int...
11.07.2025"Celebrate!" Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Hong Kong 2025HONG KONG, July 11, 2025 /PRNewswire/ -- On July 10th, Great Place To Work™ Greater China held the Best Workplaces™ in Hong Kong 2025 Awards Ceremony at Maggie Choo's. The Best Workplaces™ in Hong Kong 2025 celebration at Maggie Choo's in H...
16.06.2025Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-OncologyTeva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data gener...
14.06.2025Israel-Iran attacks and the 2 other things that drove the stock market this week-
28.05.2025Here are Wednesday’s biggest analyst calls: Nvidia, Apple, Broadcom, Microsoft, Teva, AutoZone, Vail and more-
27.05.2025Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and AsthmaBD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collabo...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In